Novo Nordisk A/S
ApoC-II mimetic peptides
Last updated:
Abstract:
The disclosure provides apolipoprotein C-II (apoC-II) mimetic peptides and methods for treating hypertriglyceridemia in a patient with an effective amount of an apoC-II mimetic peptide.
Status:
Grant
Type:
Utility
Filling date:
19 Jan 2018
Issue date:
5 Oct 2021